Abstract:The addition of long-acting β2-agonists (LABAs) to inhaled corticosteroid for the treatment of asthma in children over 5 years of age is highly beneficial in the short term at improving lung function and day-to-day symptoms. Unfortunately, the effect wanes with time in some children. In addition, some children may still experience severe exacerbations while on LABAs. It is therefore important to ensure that these children are receiving adequate doses of inhaled corticosteroid before consideration be given to s… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.